Cadila Healthcare informs about press release

24 Jun 2021 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated June 24, 2021 titled ‘Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg’. Bring this news to the notice of the members of the exchange and the investors’ at large.

The above information is a part of company’s filings submitted to BSE.


Zydus Lifesciences Share Price

890.20 -6.40 (-0.71%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×